Jennifer Taubert
2020
In 2020, Jennifer Taubert earned a total compensation of $9.5M as EVP, Worldwide Chair Pharmaceuticals at Johnson & Johnson, a 34% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,642,000 |
|---|---|
| Non-Equity Incentive Plan | $990,058 |
| Option Awards | $1,499,997 |
| Salary | $884,615 |
| Stock Awards | $4,468,928 |
| Other | $46,871 |
| Total | $9,532,469 |
Taubert received $4.5M in stock awards, accounting for 47% of the total pay in 2020.
Taubert also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $990.1K in non-equity incentive plan, $1.5M in option awards, $884.6K in salary and $46.9K in other compensation.
Rankings
In 2020, Jennifer Taubert's compensation ranked 886th out of 13,090 executives tracked by ExecPay. In other words, Taubert earned more than 93.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 886 out of 13,090 | 93rd |
Division Manufacturing | 311 out of 5,621 | 95th |
Major group Chemicals And Allied Products | 99 out of 2,254 | 96th |
Industry group Drugs | 86 out of 1,954 | 96th |
Industry Pharmaceutical Preparations | 66 out of 1,459 | 96th |
Source: SEC filing on March 10, 2021.
Taubert's colleagues
We found four more compensation records of executives who worked with Jennifer Taubert at Johnson & Johnson in 2020.